These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 7479227
1. [Level of atrial natriuretic peptide (ANP) in plasma of patients with chronic renal failure during hemodialysis]. Grzeszczak W, Kowalska K, Zukowska-szczechowska EA, Kowalski D, Snit M, Sornek E. Pol Arch Med Wewn; 1995 Feb; 93(2):107-13. PubMed ID: 7479227 [Abstract] [Full Text] [Related]
2. [Secretion of atrial natriuretic peptide and vasopressin during hemodialysis in patients with chronic renal failure]. Grzeszczak W, Sornek E, Zukowska-Szczechowska E, Mizera W, Klajnowicz J. Pol Arch Med Wewn; 1995 Sep; 94(3):195-207. PubMed ID: 8596756 [Abstract] [Full Text] [Related]
3. [Levels of endothelin and atrial natriuretic peptide (ANP) in plasma of patients with chronic renal failure treated by hemodialysis]. Kowalska K, Grzeszczak W, Kowalski D. Pol Arch Med Wewn; 1993 Nov; 90(5):334-41. PubMed ID: 8146034 [Abstract] [Full Text] [Related]
4. Plasma atrial natriuretic peptide in patients with chronic renal failure. Chen JH, Tsai JH, Lai YH, Hwang SJ. J Formos Med Assoc; 1990 Aug; 89(8):645-50. PubMed ID: 1981224 [Abstract] [Full Text] [Related]
5. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography. Metry G, Hall C, Wikström B, Källskog V, Hansell P, Danielson B. Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271 [Abstract] [Full Text] [Related]
6. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure. Hasegawa K, Matsushita Y, Inoue T, Morii H, Ishibashi M, Yamaji T. J Clin Endocrinol Metab; 1986 Oct; 63(4):819-22. PubMed ID: 2943754 [Abstract] [Full Text] [Related]
7. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease. Nishikimi T, Futoo Y, Tamano K, Takahashi M, Suzuki T, Minami J, Honda T, Uetake S, Asakawa H, Kobayashi N, Horinaka S, Ishimitsu T, Matsuoka H. Am J Kidney Dis; 2001 Jun; 37(6):1201-8. PubMed ID: 11382689 [Abstract] [Full Text] [Related]
8. Renal and hemodialysis clearances of endogenous natriuretic peptide. A clinical and experimental study. Deray G, Maistre G, Cacoub P, Barthelemy C, Eurin J, Carayon A, Masson F, Martinez F, Baumelou A, Legrand JC. Nephron; 1990 Jun; 54(2):148-53. PubMed ID: 2138254 [Abstract] [Full Text] [Related]
9. Plasma concentrations of natriuretic peptides in patients on hemodialysis. Takahashi M, Nagake Y, Ichikawa H, Kawabata K, Nakazono H, Hirata K, Ogura T, Makino H. Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825 [Abstract] [Full Text] [Related]
10. Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis. de Châtel R, Makó J, Tóth M, Barna I, Lang RE. Int Urol Nephrol; 1991 Apr; 23(2):177-83. PubMed ID: 1830872 [Abstract] [Full Text] [Related]
11. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure. Haug C, Metzele A, Steffgen J, Grünert A. Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909 [Abstract] [Full Text] [Related]
12. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment. Franz M, Woloszczuk W, Hörl WH. Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584 [Abstract] [Full Text] [Related]
14. [Response of vasoactive substance to blood pressure changes during hemodialysis in uremic patients]. Witkowicz J, Kokot F, Irzyniec T, Chudek J, Ficek R. Pol Arch Med Wewn; 1999 Sep; 102(3):763-71. PubMed ID: 10949883 [Abstract] [Full Text] [Related]
15. Comparative effects of haemodialysis and haemofiltration on plasma atrial natriuretic peptide. Raine AE, Bock A, Muller FB, Erne P, Bolli P, Brunner F, Buhler FR. Nephrol Dial Transplant; 1989 Sep; 4(3):222-7. PubMed ID: 2524680 [Abstract] [Full Text] [Related]
16. Atrial natriuretic peptide in dialysis patients under various conditions of volume homeostasis. Plum J, Grabensee B. J Intern Med; 1991 Mar; 229(3):209-16. PubMed ID: 1826125 [Abstract] [Full Text] [Related]
17. Atrial natriuretic peptide and cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure. Lettgen B, Bald M, Valleé H, Bonzel KE, Rascher W. Pediatr Nephrol; 1992 Jan; 6(1):60-4. PubMed ID: 1311187 [Abstract] [Full Text] [Related]
18. Usefulness of long axis M-mode echocardiographic measurements for optimum dialysis in patients on maintenance hemodialysis: comparison with changes in plasma levels of atrial natriuretic peptide and brain natriuretic peptide. Sugihara K, Fujimoto S, Motomiya Y, Hashimoto T, Nakamura S, Dohi K. Clin Nephrol; 2001 Aug; 56(2):140-9. PubMed ID: 11522091 [Abstract] [Full Text] [Related]